McAdams Wright Ragen’s Boston Scientific BSX Stock Holding History

McAdams Wright Ragen’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$424K	Sell	35,925 -1,825	-5%	-$23K	0.02%	289
2014 Q2	$482K	Sell	37,750 -600	-2%	-$7.8K	0.03%	262
2014 Q1	$518K	Sell	38,350 -4,500	-11%	-$59.1K	0.03%	240
2013 Q4	$515K	Buy	42,850 +3,100	+8%	+$36.6K	0.03%	238
2013 Q3	$467K	Buy	39,750 +200	+0.5%	+$2.16K	0.04%	226
2013 Q2	$367K	Buy	+39,550	New	+$335K	0.03%	244

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

McAdams Wright Ragen's BSX Position: Q3 2014 in Review

McAdams Wright Ragen reduced its Boston Scientific (BSX) stake by 4.8% in Q3 2014, selling an estimated $23K and leaving 35,925 shares worth $424K. The position accounts for 0.02% of the portfolio, ranked #289.

McAdams Wright Ragen first reported a position in BSX in Q2 2013 and has held it in 6 quarters since. The position peaked at $518K in Q1 2014. 435 funds tracked by Wall St. Rank hold BSX as of Q3 2014.

McAdams Wright Ragen held 35,925 shares of Boston Scientific worth $424K as of Q3 2014.
McAdams Wright Ragen sold 1,825 Boston Scientific shares in Q3 2014, an estimated $23K.
Boston Scientific made up 0.02% of McAdams Wright Ragen's portfolio in Q3 2014, its #289 holding.
McAdams Wright Ragen first reported a position in Boston Scientific in Q2 2013 and has held it in 6 quarters since.
McAdams Wright Ragen's Boston Scientific position peaked at $518K in Q1 2014.
435 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.